PT Mitsubishi Tanabe Pharma Indonesia, hereinafter referred to as MTID, is a Company engaged in the pharmaceutical industry with a business focus on producing and selling ethical medicines for the Domestic and Overseas markets. In terms of the domestic market MTID has contributed to support the Indonesian Government's program, namely improving the quality of life of the Indonesian people, especially in the health sector for almost 50 years.
The existence of MTID began on Saturday, July 25, 1970, in accordance with notarial deed number 75, a Company named PT Tanabe Abadi was established, which is a capital investment company from a domestic company N.V. Pharmacie Nasional based in Bandung and led by Mr. Machdi with Tanabe Seiyaku Company Limited with its Head Office in 21 Doshomuchi, 3 chome, Higashi-ku, Osaka, Japan represented by Katsunori Tanino-San. Until now, July 25 is celebrated as Company Anniversary Day.
In the beginning of its work in Indonesia, PT Tanabe Abadi conducted its first commercial production activity in November 1970, which was conducted at the Manufacturing site located at Dr. Setiabudi street number 287 Bandung, West Java.
To increase production capacity and maintain product quality, on March 29, 1986 management decided to move the Manufacturing site as well as the Head Office to Jalan Rumah Sakit number 104 Ujungberung, Bandung, West Java. In this place, it is still the center of MTID production.
With the change in capital structure and with the aim of expanding the business network, on June 1, 2003, the Company name was changed to PT Tanabe Indonesia and at the same time moved the Head Office in the heart of the Capital City of Jakarta, precisely on Tanah Abang III street number 8, Central Jakarta. While the production center has not changed, namely in the city of Bandung.
History again notes that on October 1, 2007, Tanabe Seiyaku Company Limited, which is the holding company, merged with Mitsubishi Pharma Corporation and formed a new company called Mitsubishi Tanabe Pharma Corporation (MTPC).
To maintain a good image in contributing to improving the quality of life of the Indonesian people through the production of high quality medicines, the management decided to change the Company's Name and Logo to PT Mitsubishi Tanabe Pharma Indonesia as of October 1, 2018.